Kreile, M., Rots, D., Zarina, A., Rautiainen, L., Visnevska-Preciniece, Z., Kovalova, Z., Gailite, L. (2018). Association of ARID5B Genetic Variants with Risk of Childhood B Cell Precursor Acute Lymphoblastic Leukaemia in Latvia. Asian Pacific Journal of Cancer Prevention, 19(1), 91-95. doi: 10.22034/APJCP.2018.19.1.91
Madara Kreile; Dmitrijs Rots; Agnese Zarina; Linda Rautiainen; Zelma Visnevska-Preciniece; Zhanna Kovalova; Linda Gailite. "Association of ARID5B Genetic Variants with Risk of Childhood B Cell Precursor Acute Lymphoblastic Leukaemia in Latvia". Asian Pacific Journal of Cancer Prevention, 19, 1, 2018, 91-95. doi: 10.22034/APJCP.2018.19.1.91
Kreile, M., Rots, D., Zarina, A., Rautiainen, L., Visnevska-Preciniece, Z., Kovalova, Z., Gailite, L. (2018). 'Association of ARID5B Genetic Variants with Risk of Childhood B Cell Precursor Acute Lymphoblastic Leukaemia in Latvia', Asian Pacific Journal of Cancer Prevention, 19(1), pp. 91-95. doi: 10.22034/APJCP.2018.19.1.91
Kreile, M., Rots, D., Zarina, A., Rautiainen, L., Visnevska-Preciniece, Z., Kovalova, Z., Gailite, L. Association of ARID5B Genetic Variants with Risk of Childhood B Cell Precursor Acute Lymphoblastic Leukaemia in Latvia. Asian Pacific Journal of Cancer Prevention, 2018; 19(1): 91-95. doi: 10.22034/APJCP.2018.19.1.91
Association of ARID5B Genetic Variants with Risk of Childhood B Cell Precursor Acute Lymphoblastic Leukaemia in Latvia
Riga Stradiņš University, University Scientific Laboratory of Molecular Genetics, Riga Stradiņš University, Institute of Oncology, Children’s Clinical University Hospital, Latvia.
Receive Date: 05 July 2017,
Revise Date: 01 November 2017,
Accept Date: 05 December 2017
Abstract
Background: Acute lymphoblastic leukaemia (ALL) is the most common malignancy in childhood. Despite numerous investigations very little is still known about its aetiology. However, in one genome wide association study conducted to identify the possible genetic risk factors, two allelic variations rs10821936 and rs10994982 in the 3rd intron of the ARID5B gene were identified as possible ALL risk alleles. Association between ARID5B gene variants and ALL risk was also been confirmed for different ethnic groups. Materials and Methods: Eight genetic variants in the gene ARID5B were genotyped - rs10994982, rs7908445, rs7923074, rs10821936, rs10821937, rs7896246, rs10821938 and rs7089424 in 77 ALL patients in remission and in 122 age and gender matched controls; parental samples were also genotyped in 50 cases. Results: Six out of the eight (rs7908445, rs7923074, rs10821936, rs10821937, rs7896246 and rs7089424) analysed allelic variations were identified in the case-control analysis as statistically significant risk alleles for ALL development. In the family study and using hybrid analysis, all allelic variations were significantly associated with ALL. During the study, risk haplotype was identified rs10994982/rs7908445/rs7923074/ rs10821936/ rs10821937/rs7896246/rs10821938/rs7089424 – ATACCAAG – with a frequency in cases of 0.17 and in the control group at 0.29 (chi square = 6.69, p value = 0.009). In the family association study the same haplotype showed statistical significance (chi squared = 10.3, p value = 0.001). Conclusions: Results of the study replicate and extend previously published findings for ARID5B localized allelic variants, but do not explain the mechanism of action related to the pathogenesis of ALL.
Top